2012 annual financial data
Alnylam Pharmaceuticals 2012 Operating margin
Alnylam Pharmaceuticals 2012 operating margin with verified reported values.
Direct answer
Operating margin was -194.01%.
Operating income was -129,456,000 USD and net income was -106,014,000 USD.
Operating cash flow was -115,609,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 66,725,000 USD
- Operating income
- -129,456,000 USD
- Net income
- -106,014,000 USD
- Operating cash flow
- -115,609,000 USD